The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Variation in guideline-concordant use of bone modifying agents for prostate cancer.
 
Aaron Mitchell
No Relationships to Disclose
 
Andrew Salner
Employment - Hartford HealthCare
Consulting or Advisory Role - Best Doctors, Inc
(OPTIONAL) Uncompensated Relationships - Nami Therapeutics
 
Paul Palyca
No Relationships to Disclose
 
Azeez Farooki
Consulting or Advisory Role - Ascendis Pharma; Crinetics Pharmaceuticals; Fog Pharmaceuticals; Novartis
 
Sonia Persaud
No Relationships to Disclose
 
Nirjhar Chakraborty
No Relationships to Disclose
 
Dedipya Bhamidipati
No Relationships to Disclose
 
Maria Klimchuk
No Relationships to Disclose
 
Michaela Dinan
Employment - Yale Health (I)
Honoraria - Kite/Gilead (I)
 
Michael Leapman
(OPTIONAL) Uncompensated Relationships - Veracyte
 
Allison Lipitz-Snyderman
No Relationships to Disclose
 
Anis Hamid
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer
Research Funding - Convergent Therapeutics (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Jamie Ostroff
No Relationships to Disclose
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Actinium Pharmaceuticals; Advancelle; Ambrx; Amgen; Arvinas; Convergent Therapeutics; Curium Pharma; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; Isotopia; Lantheus Medical Imaging; Mashup Media; Molecular Partners; Soffinova; Transtherabio; Wren Laboratories; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - APCCC; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis